(Q39895082)

15 September 2017

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells (English)

1 reference

15 September 2017

0 references

1 reference

4

Zvi Laron

1 reference

15 September 2017

Doron Weinstein

1

1 reference

15 September 2017

Meital Simon

series ordinal

2

1 reference

15 September 2017

Einat Yehezkel

series ordinal

3

1 reference

15 September 2017

Haim Werner

series ordinal

5

1 reference

15 September 2017

1 January 2009

1 reference

Diabetes - Metabolism: Research and Reviews

15 September 2017

1 reference

15 September 2017

25

1 reference

15 September 2017

1

1 reference

15 September 2017

41-49

1 reference

15 September 2017

1 reference

7 January 2021

Insulins today and beyond

1 reference

7 January 2021

Insulin: a novel factor in carcinogenesis

1 reference

7 January 2021

Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice.

1 reference

7 January 2021

Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities

1 reference

7 January 2021

Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor

1 reference

7 January 2021

1 reference

7 January 2021

Molecular and cellular aspects of the insulin-like growth factor I receptor

1 reference

7 January 2021

The IGF-I receptor in cancer research

1 reference

7 January 2021

The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.

1 reference

7 January 2021

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

1 reference

7 January 2021

Insulin-like growth factor 1 (IGF-1): a growth hormone

1 reference

7 January 2021

Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells

1 reference

7 January 2021

IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts.

1 reference

7 January 2021

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

1 reference

7 January 2021

The role of the IGF system in cancer growth and metastasis: overview and recent insights

1 reference

7 January 2021

The role of the insulin-like growth factor system in human cancer

1 reference

7 January 2021

The IGF‐1 receptor in cancer biology

1 reference

7 January 2021

Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk

1 reference

7 January 2021

Energy balance and cancer: the role of insulin and insulin-like growth factor-I.

1 reference

7 January 2021

Comparison of the mitogenic potency of regular human insulin and its analogue glargine in normal and transformed human breast epithelial cells

1 reference

7 January 2021

In vitro effects of growth hormone (GH) and insulin-like growth factor I and II (IGF-I and -II) on chromosome fragility and p53 protein expression in human lymphocytes

1 reference

7 January 2021

Insulin and its analogue glargine do not affect viability and proliferation of human coronary artery endothelial and smooth muscle cells

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.912

1 reference

release_ahtawdw7fzh6hgiygiugwk6swy

15 September 2017

0 references

1 reference